METASTATIC CASTRATION RESISTANT PROSTATE CANCER
Clinical trials for METASTATIC CASTRATION RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CASTRATION RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for METASTATIC CASTRATION RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer drug ITC-6146RO enters first human tests
Disease control Not yet recruitingThis early-phase trial tests a new drug called ITC-6146RO in about 100 adults with advanced or metastatic cancers (prostate, lung, breast, or other solid tumors) that have stopped responding to standard therapies. The study has two parts: first, finding a safe dose, then checking…
Matched conditions: METASTATIC CASTRATION RESISTANT PROSTATE CANCER
Phase: PHASE1 • Sponsor: IntoCell, Inc • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New pill shows promise in battle against advanced prostate cancer
Disease control Not yet recruitingThis study tests a new oral drug, TQB3201, for people with advanced prostate cancer that has spread and no longer responds to standard hormone therapy. The drug works by targeting and breaking down a key protein that fuels cancer growth. The trial aims to find safe doses and chec…
Matched conditions: METASTATIC CASTRATION RESISTANT PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC